Alejandro Dorenbaum's most recent trade in Reneo Pharmaceuticals Inc was a trade of 125,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Dec. 9, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reneo Pharmaceuticals Inc | Alejandro Dorenbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 125,000 | 125,000 | - | - | Stock option (right to buy) | |
| Reneo Pharmaceuticals Inc | Alejandro Dorenbaum | Chief Medical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Dec 2022 | 22,348 | 30,000 | - | 0 | Common Stock | |
| Reneo Pharmaceuticals Inc | Alejandro Dorenbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 100,000 | 100,000 | - | - | Stock option (right to buy) | |
| Reneo Pharmaceuticals Inc | Alejandro Dorenbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 30,000 | 52,348 | - | 0 | Common Stock |